Hi [[ session.user.profile.firstName ]]

Vaccines versus Variant: where to next for markets?

The pattern of global growth is dominated by vaccine roll outs, with the US and UK leading. Domestic UK companies to benefit.
US fiscal policy is moving from stimulus to tax increases – have earnings estimates factored this in?
Does Europe’s vaccine catch up offer a buying opportunity?
Live online Apr 29 10:00 am UTC
or after on demand 45 mins
Your place is confirmed,
we'll send you email reminders
Presented by
Steven Bell, Chief Economist
Presentation preview: Vaccines versus Variant: where to next for markets?

Network with like-minded attendees

  • [[ session.user.profile.displayName ]]
    Add a photo
    • [[ session.user.profile.displayName ]]
    • [[ session.user.profile.jobTitle ]]
    • [[ session.user.profile.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(session.user.profile) ]]
  • [[ card.displayName ]]
    • [[ card.displayName ]]
    • [[ card.jobTitle ]]
    • [[ card.companyName ]]
    • [[ userProfileTemplateHelper.getLocation(card) ]]
  • Channel
  • Channel profile
A leading provider of global investment solutions
BMO Global Asset Management (formerly F&C Investments) is a worldwide investment manager and is part of BMO Financial Group, founded in 1817 as the Bank of Montreal.

Embed in website or blog

Successfully added emails: 0
Remove all
  • Title: Vaccines versus Variant: where to next for markets?
  • Live at: Apr 29 2021 10:00 am
  • Presented by: Steven Bell, Chief Economist
  • From:
Your email has been sent.
or close